Featured Posts

Dexrazoxane Prevents Anthracycline-Related Cardiotoxicity in Childhood AML

April 30, 2020

New data from researchers at the Children’s Hospital of Philadelphia (CHOP) suggests use of dexrazoxane could provide some much-needed cardiovascular protection to pediatric patients undergoing chemotherapy for acute myeloid leukemia (AML).


Read more: https://www.mdmag.com/medical-news/dexrazoxane-prevents-anthracyclinerelated-cardiotoxicity-in-childhood-aml

Please reload

I'm busy working on my blog posts. Watch this space!

Please reload

Recent Posts
Please reload